@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" . sub:version prov:value "1"^^xsd:integer . rdf:object ns1:C0003280 "anticoagulant"; ns1:C0016055 "fibronectin"; ns1:C0086597 "mediated"; ns1:C0127400 "mediated"; ns1:C0205217 "augment"; ns1:C1280500 "effects"; ns1:C1570610 "fibronectin"; ns1:C2986495 "synergistic"; ns1:C3536711 "anticoagulant" . rdf:predicate ns3:TRIPLE_UID:1jnziuot-TRIPLE-ABSTRACT-21 "exert" . rdf:subject ns1:C0011777 "dexamethasone" . rdfs:Triple-UID ns2:TRIPLE_UID:1jnziuot-TRIPLE-ABSTRACT-21 "1jnziuot-TRIPLE-ABSTRACT-21" . rdfs:sentence rdfs:label "we's studies demonstrated that LABAs and dexamethasone exert synergistic effects that will augment both anti-inflammatory and fibronectin-mediated anticoagulant effects." . rdfs:triple rdfs:label "LABAs and dexamethasone exert synergistic effects that will augment both anti - inflammatory and fibronectin - mediated anticoagulant effects" . } sub:provenance { sub:assertion prov:generatedAtTime "2021-07-25T21:46:41.041455"^^xsd:dateTime . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "Ux6FYIbXXnk8KxxtrZ0SpywsdewHmk26x/4sf9wWvZxY03HdOc/uvkSsaoftREF+OnhRhYwfalbej6AwrajxcprnTVBr/NwJow9tEyzevMpAK87JcoUiWHKEqY2an4jB6auPPtpyn9M7GQ30Yz1RJqFQUJDEa5Q4gK9FpTH1ALw="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-07-25T21:46:41.041455"^^xsd:dateTime; prov:wasAttributedTo . }